Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma
暂无分享,去创建一个
[1] W. Wang,et al. MicroRNA-211-5p promotes the apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11. , 2020, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[2] J. Ajani,et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression , 2020, Cell Research.
[3] Xiaoli Tang,et al. miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ , 2019, Bioscience reports.
[4] S. Tsunoda,et al. MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer , 2019, Cancers.
[5] Li Ding,et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma , 2019, Cell.
[6] Mohammad Hossein Khosravi,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 , 2019, JAMA oncology.
[7] J. Arnaud,et al. A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer Agent , 2018, Cancers.
[8] O. Ohara,et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC , 2018, Cell.
[9] J. McCubrey,et al. Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update , 2018, International Journal of Molecular Sciences.
[10] L. Thompson,et al. Omega-3 Polyunsaturated Fatty Acids Time-Dependently Reduce Cell Viability and Oncogenic MicroRNA-21 Expression in Estrogen Receptor-Positive Breast Cancer Cells (MCF-7) , 2018, International journal of molecular sciences.
[11] Ge-liang Xu,et al. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[12] Yi-huan Luo,et al. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma , 2017, Medicine.
[13] Steven J. M. Jones,et al. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma , 2017, Cell.
[14] Hongmei Zheng,et al. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] M. Hou,et al. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance. , 2017, Oncology reports.
[16] Jian-jun Li,et al. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1 , 2017, British Journal of Cancer.
[17] Sang Wook Kim. [The Role of MicroRNAs in Colorectal Cancer]. , 2017, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[18] R. Ouellette,et al. 17&bgr;-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells , 2017, Carcinogenesis.
[19] Zhongwei Cao,et al. MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma , 2016, Scientific Reports.
[20] Yi Zhang,et al. Tumor‐suppressive functions of long‐chain acyl‐CoA synthetase 4 in gastric cancer , 2016, IUBMB life.
[21] Shu-lin Yang,et al. Global Transcriptomic Profiling of Cardiac Hypertrophy and Fatty Heart Induced by Long-Term High-Energy Diet in Bama Miniature Pigs , 2015, PloS one.
[22] Xin Yu,et al. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2 , 2015, Oncotarget.
[23] K. Tomczak,et al. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.
[24] A. Schetter,et al. The Role of MicroRNAs in Colorectal Cancer , 2012, Cancer journal.
[25] S. Volinia,et al. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes , 2012, Leukemia.
[26] B. Burwinkel,et al. Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.
[27] C. López-Otín,et al. Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells , 2010, PloS one.
[28] C. Creighton,et al. Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity. , 2010, Translational oncology.
[29] Feng-ping Huang,et al. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. , 2010, Archives of medical research.
[30] A. Hamsten,et al. Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects , 2007, Diabetes.
[31] M. Kim,et al. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells , 2007, Experimental & Molecular Medicine.
[32] Ashley M. Sherrid,et al. Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator–Activated Receptor-γ–Independent Mechanism in Human Arterial Smooth Muscle Cells and Macrophages , 2007, Diabetes.
[33] Joel S Parker,et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.
[34] Brian S. Roberts,et al. The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[36] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[37] M. Kim,et al. Fatty acid‐CoA ligase 4 is overexpressed in human hepatocellular carcinoma , 2003, Cancer science.
[38] H. Ropers,et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation , 2002, Nature Genetics.
[39] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.
[40] S. Barik,et al. MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. , 2011, Molecular and cellular pharmacology.
[41] A. Jemal,et al. Global Cancer Statistics , 2011 .
[42] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..